OUR NEWS - COVID-19

27
May

COVID-19 and clinical trials : point of view of Rémi Quirion

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Rémi Quirion, Chief Scientist of Quebec.  Q. How do you think the COVID-19 pandemic will alter current and future clinical

Read more

25
May

COVID-19 and clinical trials : point of view of Alan Bernstein

COVID-19 and clinical trials : point of view of Alan Bernstein In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Alan Bernstein, President and CEO, CIFAR. Q. How do you

Read more

18
May

COVID-19 and clinical trials : point of view of Dominique Johnson

COVID-19 and clinical trials : point of view of Dominique Johnson In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dominique Johnson, General Manager, McPeak-Sirois Group for Clinical Research in

Read more

13
May

COVID-19 and clinical trials : point of view of Julie Autmizguine

COVID-19 and clinical trials : point of view of Julie Autmizguine In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Julie Autmizguine, Assistant Director of Clinical Research, Sainte-Justine UHC

Read more

11
May

COVID-19 and clinical trials : point of view of Luc Feldmann

COVID-19 and clinical trials : point of view of Luc Feldmann In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Luc Feldmann, Director, International Centre of Therapeutic Research, Servier Canada.

Read more

7
May

COVID-19 and clinical trials : point of view of Angela Genge

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Angela Genge, Neurologist and Director, Clinical Research Unit, Montreal Neurological Institute-Hospital.

4
May

COVID-19 and clinical trials : point of view of Jean-Claude Tardif

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Jean-Claude Tardif, Research Director, Montreal Heart Institute and COLCORONA clinical trial investigator.

29
Apr

COVID-19 and clinical trials : point of view of Vincent Poitout

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Vincent Poitout, Professor, Université de Montréal and Director, CRCHUM.

28
Apr

COVID-19 and clinical trials : point of view of Monique Lacroix

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Monique Lacroix, Country Head, Development Operations (Clinical Research), Novartis Pharmaceutical Canada Inc.

21
Apr

COVID-19 and clinical trials : point of view of Dr. Gerald Batist

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders
in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following
statements detail the point of view of Dr. Gerald Batist, Deputy Director and Senior Investigator, Jewish
General Hospital’s Lady Davis Institute.

20
Apr

COVID-19 and clinical trials : point of view of Vatche Bartekian

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and look for ways to adapt. The following statements detail the point of view of Vatche Bartekian, President of Vantage BioTrials Inc.

15
Apr

COVID-19 and clinical trials : point of view of Marc Rivière 

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and look for ways to adapt. The following statements detail the point of view of Marc Rivière, Chief Medical Officer, TVM Capital and Chairman of the Board of Directors, CATALIS Québec.